A study of the Pfizer vaccine conducted on coronaviruses with variances in the spike protein, finds that the vaccine maybe effective on both the UK and
ANKARA The COVID-19 vaccine developed by American pharmaceutical firm Pfizer and its German partner BioNTech can protect against a mutation found in two
The entire world had been waiting for months for a vaccine against COVID-19. But now that we have them, how effective are they with these new variants of the coronavirus discovered in the UK and South Africa that spread more rapidly. Pfizer and BioNTech just published some results of a study done here at the University of Texas Medical Branch in Galveston where scientists looked at this new variant. They ran some tests and compared them to human.
New research suggests Pfizer’s COVID-19 vaccine can protect against a mutation found in the two more-contagious variants of the coronavirus that have erupt
As the coronavirus continues to spread in what is believed to be a post-holiday surge, the United States has reported more than 21.6 million virus cases and.